Literature DB >> 9689131

Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase.

S Couillard-Després1, Q Zhu, P C Wong, D L Price, D W Cleveland, J P Julien.   

Abstract

To investigate the role of neurofilaments in motor neuron disease caused by superoxide dismutase (SOD1) mutations, transgenic mice expressing a amyotrophic lateral sclerosis-linked SOD1 mutant (SOD1(G37R)) were mated with transgenic mice expressing human neurofilament heavy (NF-H) subunits. Unexpectedly, expression of human NF-H transgenes increased by up to 65%, the mean lifespan of SOD1(G37R) mice. Microscopic examination corroborated the protective effect of NF-H protein against SOD1 toxicity. Although massive neurodegeneration occurred in 1-yr-old mice expressing SOD1(G37R) alone, spinal root axons and motor neurons were remarkably spared in doubly SOD1(G37R);NF-H-transgenic littermates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689131      PMCID: PMC21389          DOI: 10.1073/pnas.95.16.9626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments.

Authors:  Q Zhu; S Couillard-Després; J P Julien
Journal:  Exp Neurol       Date:  1997-11       Impact factor: 5.330

2.  Decreased neurofilament gene expression is an index of selective axonal hypotrophy in ageing.

Authors:  G A Kuchel; T Poon; K Irshad; C Richard; J P Julien; T Cowen
Journal:  Neuroreport       Date:  1997-02-10       Impact factor: 1.837

3.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

Review 4.  Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.

Authors:  P H Tu; M E Gurney; J P Julien; V M Lee; J Q Trojanowski
Journal:  Lab Invest       Date:  1997-04       Impact factor: 5.662

5.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease.

Authors:  Z Xu; L C Cork; J W Griffin; D W Cleveland
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

6.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

Authors:  T L Williamson; L I Bruijn; Q Zhu; K L Anderson; S D Anderson; J P Julien; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Parvalbumin is a marker of ALS-resistant motor neurons.

Authors:  J L Elliott; W D Snider
Journal:  Neuroreport       Date:  1995-02-15       Impact factor: 1.837

8.  Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons.

Authors:  C Bergeron; K Beric-Maskarel; S Muntasser; L Weyer; M J Somerville; M E Percy
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

9.  Axonal atrophy in aging is associated with a decline in neurofilament gene expression.

Authors:  I M Parhad; J N Scott; L A Cellars; J S Bains; C A Krekoski; A W Clark
Journal:  J Neurosci Res       Date:  1995-06-15       Impact factor: 4.164

10.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  42 in total

1.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

Review 3.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

Review 4.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

Review 5.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 6.  A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.

Authors:  Kari A Trumbull; Joseph S Beckman
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 7.  Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Authors:  P C Wong; H Cai; D R Borchelt; D L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

8.  Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.

Authors:  Xiangyou Hu; Qi Shi; Xiangdong Zhou; Wanxia He; Hong Yi; Xinghua Yin; Marla Gearing; Allan Levey; Riqiang Yan
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

9.  Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.

Authors:  Artem Kaplan; Krista J Spiller; Christopher Towne; Kevin C Kanning; Ginn T Choe; Adam Geber; Turgay Akay; Patrick Aebischer; Christopher E Henderson
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

10.  The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.

Authors:  Haruhisa Inoue; Kayoko Tsukita; Takuji Iwasato; Yasuyuki Suzuki; Masanori Tomioka; Minako Tateno; Masahiro Nagao; Akihiro Kawata; Takaomi C Saido; Masayuki Miura; Hidemi Misawa; Shigeyoshi Itohara; Ryosuke Takahashi
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.